These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 7508631)
1. [Prostate-specific antigen: the most useful marker for prostate cancer]. Janssen T; Schulman C Rev Med Brux; 1993; 14(9-10):279-83. PubMed ID: 7508631 [TBL] [Abstract][Full Text] [Related]
2. [Prostate-specific antigen: an evaluation 15 years after its discovery]. Janssen T; Schulman C Prog Urol; 1994 Apr; 4(2):171-80. PubMed ID: 7515305 [TBL] [Abstract][Full Text] [Related]
3. [Use of prostate specific antigen. A review]. Brasso K; Skaarup P; Roosen JU; Iverson P Ugeskr Laeger; 1998 Jul; 160(31):4510-6. PubMed ID: 9700305 [TBL] [Abstract][Full Text] [Related]
4. The prostate specific antigen. Its use as a tumor marker for prostate cancer. Kantoff PW; Talcott JA Hematol Oncol Clin North Am; 1994 Jun; 8(3):555-72. PubMed ID: 8707772 [TBL] [Abstract][Full Text] [Related]
5. The value of prostate-specific antigen in the management of localized prostatic cancer. Walsh PC; Oesterling JE; Epstein JI; Bruzek DJ; Rock RC; Chan DW Prog Clin Biol Res; 1989; 303():27-33. PubMed ID: 2476820 [TBL] [Abstract][Full Text] [Related]
6. Preoperative prostate specific antigen doubling time and velocity are strong and independent predictors of outcomes following radical prostatectomy. Sengupta S; Myers RP; Slezak JM; Bergstralh EJ; Zincke H; Blute ML J Urol; 2005 Dec; 174(6):2191-6. PubMed ID: 16280762 [TBL] [Abstract][Full Text] [Related]
7. [Advanced prostate cancer with normal serum prostate-specific antigen values]. Komura T; Yamagiwa K; Ogura H; Kohjimoto Y; Ohkawa T; Inagaki T; Ebisuno S; Senzaki A Hinyokika Kiyo; 1998 May; 44(5):303-6. PubMed ID: 9656099 [TBL] [Abstract][Full Text] [Related]
8. [Value of determining prostate specific antigen in follow-up of prostatic cancer]. Sadeh AD; Mukamel E; Galili Y; Nussbaum B; Regev D; Servadio C Harefuah; 1993 Aug; 125(3-4):69-74, 128. PubMed ID: 7693556 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of serum markers for prostate cancer. Stenman UH; Abrahamsson PA; Aus G; Lilja H; Bangma C; Hamdy FC; Boccon-Gibod L; Ekman P Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759 [TBL] [Abstract][Full Text] [Related]
10. Pre-operative percent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10 ng/ml. Shariat SF; Abdel-Aziz KF; Roehrborn CG; Lotan Y Eur Urol; 2006 Feb; 49(2):293-302. PubMed ID: 16387412 [TBL] [Abstract][Full Text] [Related]
11. Tumor markers. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993. Stamey TA; Ekman PE; Blankenstein MA; Cooper EH; Kontturi M; Lilja H; Oesterling JE; Stenman UH; Turkes A Scand J Urol Nephrol Suppl; 1994; 162():73-87; discussion 115-27. PubMed ID: 7529430 [TBL] [Abstract][Full Text] [Related]
12. Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival. Doherty AP; Bower M; Smith GL; Miano R; Mannion EM; Mitchell H; Christmas TJ Br J Cancer; 2000 Dec; 83(11):1432-6. PubMed ID: 11076649 [TBL] [Abstract][Full Text] [Related]
13. [PSA kinetics after total prostatectomy]. Riedinger JM; Eche N; Fulla Y; Thuillier F Ann Biol Clin (Paris); 2009; 67(1):39-46. PubMed ID: 19189884 [TBL] [Abstract][Full Text] [Related]
14. [Prostate-specific antigen as a tumor marker of prostate carcinoma]. Wymenga LF; Mensink HJ Ned Tijdschr Geneeskd; 1999 Aug; 143(34):1733-8. PubMed ID: 10494319 [TBL] [Abstract][Full Text] [Related]
15. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml. Stamey TA; Johnstone IM; McNeal JE; Lu AY; Yemoto CM J Urol; 2002 Jan; 167(1):103-11. PubMed ID: 11743285 [TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen (PSA) in the monitoring of prostate cancer after radical prostatectomy and external beam radiation. Schaefer U; Witt F; Schueller P; Micke O; Willich N Anticancer Res; 2000; 20(6D):4989-92. PubMed ID: 11326654 [TBL] [Abstract][Full Text] [Related]
17. Spurious prostate-specific antigen (PSA) recurrence after radical prostatectomy: interference by human antimouse heterophile antibodies. Park S; Wians FH; Cadeddu JA Int J Urol; 2007 Mar; 14(3):251-3. PubMed ID: 17430267 [TBL] [Abstract][Full Text] [Related]
18. Accuracy of predicting long-term prostate specific antigen outcome based on early prostate specific antigen recurrence results after radical prostatectomy. Soergel TM; Koch MO; Foster RS; Bihrle R; Wahle G; Gardner T; Jung SH J Urol; 2001 Dec; 166(6):2198-201. PubMed ID: 11696735 [TBL] [Abstract][Full Text] [Related]
19. Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy. Shariat SF; Kattan MW; Song W; Bernard D; Gottenger E; Wheeler TM; Slawin KM Cancer Res; 2003 Sep; 63(18):5874-8. PubMed ID: 14522912 [TBL] [Abstract][Full Text] [Related]
20. Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy. Shariat SF; Gottenger E; Nguyen C; Song W; Kattan MW; Andenoro J; Wheeler TM; Spencer DM; Slawin KM Cancer Res; 2002 Oct; 62(20):5974-9. PubMed ID: 12384565 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]